Related Experiment Video
Updated: May 17, 2026

Biaxial Mechanical Characterizations of Atrioventricular Heart Valves
Published on: April 9, 2019
Bicuspid aortic valve: inter-racial difference in frequency and aortic dimensions
Sonal Chandra1, Roberto M Lang, Jeremy Nicolarsen
1Department of Medicine, Section of Cardiology, The University of Chicago, Chicago, IL 60637, USA.
Insights
This study found that African-American patients with bicuspid aortic valve (BAV) have smaller aortic dimensions than Caucasian patients, despite having more cardiovascular risk factors. Race may influence BAV disease progression.
Area of Science:
- Cardiology
- Genetics
- Public Health
Background:
- Bicuspid aortic valve (BAV) is a prevalent congenital heart defect.
- BAV is a leading cause of aortic valve replacement surgery.
Purpose of the Study:
- To investigate racial disparities in bicuspid aortic valve (BAV) patients.
- To compare Caucasian (C) and African-American (AA) patients regarding BAV morphology, stenosis/insufficiency severity, and aortic dilation.
Main Methods:
- Retrospective analysis of 183 patients with BAV from an echocardiographic database.
- Comprehensive assessment of aortic dimensions, valve morphology and function, and cardiovascular risk factors.
- Comparison of BAV characteristics between Caucasian and African-American cohorts.
Main Results:
- BAV is less frequent in African-Americans (0.17%) compared to Caucasians (1.1%).
- African-American patients were older and had higher hypertension rates.
- Caucasian patients exhibited significantly larger aortic dimensions (annulus, sinuses of Valsalva, sinotubular junction, ascending aorta) than African-American patients, even after adjusting for comorbidities.
Conclusions:
- This study highlights significant racial differences in bicuspid aortic valve (BAV) patients.
- African-American patients with BAV show reduced aortic dimensions despite increased cardiovascular risk factors.
- Race may act as a disease modifier in the heterogeneous population with BAV.
Objectives:
The objective of this study was to examine the similarities and differences in Caucasian (C) and African-American (AA) patients with bicuspid aortic valve (BAV) with respect to morphology, severity of aortic stenosis/insufficiency, and aortic dilation.
Background:
BAV is a common congenital valve abnormality, accounting for a large number of valve replacements.
Methods:
A total of 229 patients with the diagnostic code BAV were identified retrospectively from our computerized adult echocardiographic database, which consists of 91,896 studies performed at the University of Chicago Medical Center from 1998 to 2009, representing 40,878 patients. Of those, 183 patients with BAV were included in this retrospective BAV single-center cohort study and reanalyzed with a comprehensive assessment of aortic dimensions, aortic valve morphology and function, clinical cardiovascular risk factors, and patient characteristics.
Results:
Of the 183 patients with BAV, 138 were C and 45 were AA. Our echocardiographic database encompasses approximately 65% AA, 31% C, and 4% other races, for an estimated frequency of BAV in AA patients of 0.17% and a frequency in C patients of 1.1% (p = 0.001). There were no significant inter-racial differences regarding sex, height, weight, hyperlipidemia, diabetes, tobacco use, cardiac medications, and left ventricular ejection fraction. The AA cohort was older (age 50 ± 17 years vs. 43 ± 17 years, p < 0.05) and had a higher prevalence of hypertension (51% vs. 24%, p < 0.05). After adjusting for comorbidities, aortic dimensions were larger in C (C vs. AA: annulus, 2.4 ± 0.4 vs. 2.1 ± 0.4 cm; sinuses of Valsalva, 3.4 ± 0.7 vs. 3.1 ± 0.6 cm; sinotubular junction, 3.0 ± 0.6 vs. 2.6 ± 0.5 cm; and ascending aorta, 3.5 ± 0.7 vs. 3.2 ± 0.5 cm; all p values <0.05).
Conclusions:
This is the first study to report racial differences among patients with BAV with reduced aortic dimensions in AA patients despite the presence of more risk factors, suggestive of marked heterogeneity in the BAV population and indicating race as a potential disease modifier in BAV.
Related Concept Videos
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic Regurgitation I: Introduction
Mitral Stenosis I: Introduction
Aortic Regurgitation III: Medical Management
